MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL‐Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway

Yuxin Wang(First Affiliated Hospital Zhejiang University), Fengchao Zhao(First Affiliated Hospital Zhejiang University)

Oxidative Medicine and Cellular Longevity

January 1, 2022

10.1155/2022/7727006

Cited by 11

Related Papers

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL

|Molecular Medicine|2022|11

StemRegenin 1 attenuates the RANKL-induced osteoclastogenesis via inhibiting AhR-c-src-NF-κB/p-ERK MAPK-NFATc1 signaling pathway

|iScience|2024|10